|
|
| Biotechnologies Et Génétique > Etude de marché sectorielle |
| The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets |
|
|
|
|
€ 953,48 |
Editeur
: |
Business Insight |
Langue
: |
Anglais |
Date de publication : |
Janvier 2002 |
Taille du document : |
150 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 72 pages | Avril 2003 | Anglais
|
|
|
| Main
focus: |
genomics,drug discovery,proteomics,microarray,...,...
|
| Research
focus: |
market size and estimates,demand analysis, |
| Geographic
focus: |
switzerland,usa,austria,japan,germany,france,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Human Cloning: Economics and Ethics
36 pages | Mars 2003 |
Human cloning has moved from science-fiction novels, to science laboratories.
Pro-human cloning companies are racing to create the first cloned child, or make a breakthrough in stem cell research, |
850,00 €
|
| |
| |
Carbohydrate Therapeutics IRCD
pages | Juillet 2001 |
Carbohydrates are the only class of biological molecule (there are four main classes: nucleic acids, proteins, lipids, and carbohydrates - commonly known as sugars), that can be found in direct associ |
1 200,00 €
|
| |
| |
The Biotechnology Industry in US & Europe
22 pages | Mai 2002 |
A new report by RocSearch, The Biotechnology Industry in US & Europe, gives an overview of the global biotechnology industry.
It emphasizes current and emerging technologies including monoclonal an |
500,00 €
|
| |
| |
04-012: How Life Scientists Buy Products: Implications for Effective Channel Management
303 pages | Mars 2004 |
This report is designed to help suppliers understand how researchers place orders and what drives them to use one method over another |
880,00 €
|
| |
| |
Functional Proteomics and Emerging Bio-IT market
pages | Novembre 2002 |
The proteomic technique is not only limited to the study of one or few cellular products but also allows for qualitative and a quantitative measurement of several hundreds of proteins produced during |
250,00 €
|
| |
| |
Genomic Revolution: Trends & Opportunities
30 pages | Octobre 2002 |
Computational advancements in Genomic technology have brought a revolution in the field of application of Pharmaco-Therapy.
Companies are diversifying their business prospect from medical chemistry |
600,00 €
|
| |
| |
03-018: Market Opportunities in Cytokine & Growth Factor Research
170 pages | Mai 2003 |
This report identifies preferred quantification and activity assays, new research trends and the most popular suppliers of antibodies, recombinant proteins and DNA microarrays |
800,00 €
|
| |
| |
Revolutionise Drug Discovery through Genomics & Proteomics Study
10 pages | Novembre 2002 |
Genomics and Proteomics are complementary technologies of biological research.
The potential of these technologies for biomedical revolution will be realized by integrating them into the drug disc |
200,00 €
|
| |
| |
The Pharmacogenomics Outlook
174 pages | Août 2000 |
Pharmaceutical companies are coming under increasing pressure to increase the quality of their products, and optimize and accelerate drug discovery and development.
By identifying differenc |
955,00 €
|
| |
| |
Outsourcing in the Biotech Indsutry
20 pages | Juillet 2002 |
Outsourcing is revolutionising the biotech industry.
Companies have realised that with outsourcing, they can utilise their synergies and work together to deliver products at a faster rate.
The e |
400,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| The Genomics Outlook To 2005: Transforming pharmaceutical and diagnostic markets |
|
|
Genomics is quietly transforming the pharmaceutical industry. Companies are
moving from medicinal chemistry based drug discovery and development, to using
information provided by genomics. Virtually all of the major pharmaceutical
houses have either formed partnerships with genomics firms that began to emerge
in the early 1990s or have created in-house genomics divisions.
The Genomics Outlook to 2005: Transforming pharmaceutical and diagnostic markets,
a new report by Reuters Business Insight, examines new genomic approaches
to drug discovery and development, focusing on how these technologies can be
used most effectively and in a highthroughput capacity. Case studies analyzing
applications of genomic technologies to specific disease-related research are
provided, and future trends and developments are forecast.
|
|
CHAPTER 1: INTRODUCTION
CHAPTER 2: OVERVIEW OF GENOMICS
CHAPTER 3: GENOMICS TECHNOLOGY & INDUSTRY
CHAPTER 4: HOW GENOMICS IS REVOLUTIONIZING HEALTH CARE
CHAPTER 5: PATENTS
CHAPTER 6: BUSINESS ANALYSIS
|
|
|
PPLSEN
|
|
|
|
|
